Literature DB >> 2497039

Two-year toxicity and carcinogenicity studies of ampicillin trihydrate and penicillin VK in rodents.

J K Dunnick1, S L Eustis, J E Huff, J K Haseman.   

Abstract

Toxicology and carcinogenesis studies of ampicillin trihydrate and penicillin VK, two widely used beta-lactam antibiotics, were performed in F344/N rats and B6C3F1 mice. In these studies ampicillin trihydrate was administered for 2 years to rats at doses of 0, 750, or 1500 mg/kg and to mice at doses of 0, 1500, or 3000 mg/kg, and penicillin VK was administered to rats and mice at doses of 0, 500, or 1000 mg/kg. Both drugs were administered by oral gavage in corn oil. Toxic lesions of the stomach were seen in rats and mice after ampicillin trihydrate administration and in mice after penicillin VK administration. In male rats that received ampicillin trihydrate there was a marginal increase in incidence of mononuclear cell leukemia and pheochromocytomas of the adrenal gland medulla. There was no evidence for carcinogenic activity in female rats or male and female mice after ampicillin trihydrate administration or in rats and mice after penicillin VK administration.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2497039     DOI: 10.1016/0272-0590(89)90042-0

Source DB:  PubMed          Journal:  Fundam Appl Toxicol        ISSN: 0272-0590


  3 in total

Review 1.  The legacy of the F344 rat as a cancer bioassay model (a retrospective summary of three common F344 rat neoplasms).

Authors:  Robert R Maronpot; Abraham Nyska; Jennifer E Foreman; Yuval Ramot
Journal:  Crit Rev Toxicol       Date:  2016-06-09       Impact factor: 5.635

2.  Sister-chromatid exchange analysis on long-term benzathine penicillin for secondary prophylaxis of rheumatic fever.

Authors:  R Dündaröz; T Ozisik; V Baltaci; K Karapinar; H I Aydin; M Denli
Journal:  Indian J Pediatr       Date:  2001-02       Impact factor: 1.967

3.  ssDNA recombineering boosts in vivo evolution of nanobodies displayed on bacterial surfaces.

Authors:  Yamal Al-Ramahi; Akos Nyerges; Yago Margolles; Lidia Cerdán; Gyorgyi Ferenc; Csaba Pál; Luis Ángel Fernández; Víctor de Lorenzo
Journal:  Commun Biol       Date:  2021-10-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.